Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

U.S. Disinfecting Cap Market – Market Insights

Disinfecting caps are attached to injection ports of needle-free connectors to ensure that needle-free connectors are always clean. These caps protect the needleless connectors from contamination which reduce the risk of hospital acquired infections such as central line blood stream infection (CLABSI).  

Central line procedures pose a risk of hospital acquired infections such as central line blood stream infection (CLABSI) and catheter associated urinary tract infection (CAUTI). Central line blood stream infection (CLABSI) is the major infection caused due to the use of central line devices as it accesses a major vein which is close to the heart. In some severe health conditions, it has to be inserted in the vein for weeks or months, which can cause central line blood stream infections. Disinfecting caps are used for the prevention of central line-associated bloodstream infection (CLABSI).

Disinfecting caps are widely used to protect the access points/ports of hemodialysis central venous catheters (HDCVCs). During hemodialysis, the repeated exposure of CVCs to the patients' veins may increase the risk of a catheter-related bloodstream infection (CRBSI) in patients.

The U.S. disinfecting cap market is expected to be valued at US$ 359.3 million in 2019, and is expected to exhibit a CAGR of 10.7% over the forecast period (2019-2027).

Increasing incidence of hospital-acquired infections is expected to propel the market growth over the forecast period

Infections acquired in hospitals and other healthcare settings are considered as the most frequent adverse event affecting millions of patients in hospitals and healthcare settings. According to the Centers for Disease Control and Prevention (CDC) estimation in January 2020, each year, an estimated 30,100 central line-associated bloodstream infections (CLABSI) occur in intensive care units and acute care facilities in the U.S. CLABSI is a serious blood-related infection, which may prolong hospital stays and increase the risk of mortality. The increasing incidence of central line-associated bloodstream infections (CLABSI) and other hospital acquired infections can be controlled and reduced by using disinfecting caps, which is predicted to favour the growth of the U.S. disinfecting cap.

Figure 1. U.S. Disinfecting Cap Market Share (%), by Application, 2027

U.S. Disinfecting Cap  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2020)

Increasing product approvals and launches are expected to propel the market growth over the forecast period

Key players in the market are focusing on increasing product approvals and launching innovative disinfecting caps to prevent infections associated with the use of central line IV catheters. Increasing product approval of such new products is expected to drive growth of the U.S. disinfecting cap market over the forecast period. For instance, On February 27, 2017, 3M launched the 3M Curos Stopper Disinfecting Cap which assists clinicians by providing passive disinfection solutions for female luers. The Curos stopper disinfecting cap is the latest offering in the Curos Disinfecting Port Protector family to reduce contamination risk in needleless connectors, male luers, and Tego hemodialysis connectors.

However, availability of antimicrobial coated central venous catheters such as Certofix protect (B.Braun), Cook Spectrum Central Venous Catheter (Cook Medical), and ARROW CVC with ARROWg+ard Technology (Teleflex), which are impregnated with antimicrobial agents are expected to negatively affect demand for disinfecting caps in the near future.

Key Players

Major players operating in the U.S. disinfecting cap market include ICU Medical, C.R. Bard, Becton, Dickinson and Company, 3M, Merit Medical Systems, and other prominent players.

Peripheral IV Catheters (PIVC) are commonly used intravenous devices in hospital settings. PIVC are inserted in small peripheral veins for administration of medications, fluids and/or blood products, and also for blood sampling. Peripheral IV catheter insertion is one of the most common invasive procedures in hospital settings. PIVC are intravenous devices that are used more frequently which can increase risk of infection. As a result, special infection control measures have been applied for such IV devices. In order to avoid contamination risk, most hospitals use PIV bundles, which include disinfecting caps and tips. Central venous line procedures are generally used for hemodynamic monitoring, administration of drugs likely to induce phlebitis, hemodialysis, lack of peripheral venous access, and others. Hence, disinfecting caps are widely used for prevention of central line-associated bloodstream infection (CLABSI).

Market Dynamics

Increasing adoption of inorganic growth strategies such as mergers, agreements and collaborations by key players operating in the market is expected to propel the market growth over the forecast period. For instance, in December 2017, Becton, Dickinson (BD) and Company acquired C. R. Bard, Inc. (Bard). With this acquisition, BD complemented its Interventional segment and medical segment with C.R. Bards' products.

Key features of the study:

  • This report provides in-depth analysis of the U.S. disinfecting cap market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2019–2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the U.S. disinfecting cap market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include ICU Medical, C.R. Bard, Becton, Dickinson and Company, 3M, Merit Medical Systems, and other prominent players.
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future product launches, Product Type up-gradation, market expansion, and marketing tactics
  • The U.S. disinfecting cap market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the U.S. disinfecting cap market

Detailed Segmentation:

  • U.S. Disinfecting cap Market, By Application:
    • Central Venous Line
    • Peripheral IV Catheters
    • Others
  • U.S. Disinfecting cap Market, By End User:
    • Hospital and Clinics
    • Ambulatory/Outpatient Surgical Centers
    • Others
  • Company Profiles
    • ICU Medical*
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
      • R. Bard
      • Becton, Dickinson and Company
      • 3M
      • Merit Medical Systems

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Application
      • Market Snippet, By End User
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Regulatory Scenario
    • Reimbursement Scenario
    • Merger and Acquisition Scenario
    • PEST Analysis
    • Porter’s Analysis
    • Advantages of Disinfecting Cap
    • Brand Market Presence By Application
  4. U.S. Disinfecting Cap Market, By Application, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Central Venous Line
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Peripheral IV Catheters
      •  Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  5. U.S. Disinfecting Cap Market, By End User, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospitals and Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Ambulatory/Outpatient Surgical Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
      • ICU Medical*
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • R. Bard
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Becton, Dickinson and Company
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • 3M
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Merit Medical Systems
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
    • Analyst Views
  7. Section
    • References
    • Research Methodology
    • About Us and Sales Contact

*Browse 8 market data tables and 12 figures on "Disinfecting Cap Market” – U.S. forecast to 2027.

Frequently Asked Questions

The U.S. disinfecting cap market is estimated to surpass US$ 810.3 Million by 2027.
Which are the prominent U.S. disinfecting cap market players?
Availability of antimicrobial coated central venous catheters such as Certofix protect (B.Braun), Cook Spectrum Central Venous Catheter (Cook Medical), and ARROW CVC with ARROWg+ard Technology (Teleflex) is one of the major factors that is expected to hamper growth of the market over the forecast period.
Increasing incidence of hospital-acquired infections is one of the major factors that is expected to propel growth of the market over the forecast period.
The U.S. disinfecting cap market is estimated to exhibit a CAGR of 10.7% during the forecast period (2019-2027).
The U.S. disinfecting cap market is expected to be valued at US$ 359.3 million in 2019.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner